Veristat

Your TLF process is costing you more than you think. Database lock happens. Then the wait begins. Four to six weeks for tables, figures, and listings your final report or submission cannot move without. What if programming could be automated? What difference would it make? For 30+ years, Veristat's biostatisticians have refined how TLFs are produced and reviewed. What started as a semi-automated internal approach has evolved into a fully autonomous capability, built on that institutional knowledge and now available to sponsors who can’t afford to lose weeks at the finish line. Delays add risk, and rework adds more. It doesn’t have to. Join Kyle McBride, VP of AI Innovation, and Mark McBride, VP of Biostatistics and Statistical Programming, for a live session on what actually changes when the manual programming step is gone. We will introduce Veristat's new capability platform for automated, submission-ready TLF generation, and cover: - Where the 4-6 weeks actually go, and why the bottleneck shows up every time - What automated, validated TLFs look like across real studies - Why deterministic execution matters in a GxP environment - How collaborative, transparent review improves quality while reducing time and effort - What slipping TLF timelines cost your submission Days instead of weeks is possible. So is much more visibility to the client, so we can collaborate as we finalize the outputs. 📅 April 30, 2026 🕛 12pm EST | 5pm BST ⏱ 45 minutes, live with Q&A

Complex clinical trials require more than strong science. They require the right partnership. Our latest case study highlights how Veristat worked with Cook MyoSite on an adaptive study evaluating an autologous cell therapy. The collaboration brought together biostatistical expertise, careful study design, and close sponsor–CRO coordination to support a complex regenerative medicine program. Explore the case study in the article below. What challenges have you encountered with adaptive trial design or execution? We’d welcome your perspective in the comments below.

Every detail matters in a regulatory marketing application. Are you covering them all? Our infographic shows how strategic planning, data integrity, and regulatory expertise come together for success. Don’t guess, get the proven process. Learn more. #RegulatoryStrategy #DrugDevelopment #ClinicalResearch #MarketingApplication #veristat

Meet Veristat at SCOPE 2026, Booth 1037. FDA & EMA success stories. Proven global know-how. Connect with Us.

20 approvals in 24 months. 170+ NDAs/BLAs/MAAs prepared. Visit Veristat at SCOPE Booth 1037 to learn how we transform complex data into submission-ready evidence, fast. Book your booth visit.

Join Veristat at SCOPE 2026, Booth 1037. Discover how we accelerate your clinical development timeline with proven regulatory expertise and advanced data analytics. Schedule a meeting.